Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
136.94
+4.32 (3.26%)
At close: Jun 6, 2025, 4:00 PM
136.50
-0.44 (-0.32%)
After-hours: Jun 6, 2025, 7:58 PM EDT
Krystal Biotech Analyst Ratings
Total Analysts
8
Consensus Rating
Strong Buy
Price Target
$211.13
Upside
+54.18%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Hold Maintains $215 → $155 | Hold | Maintains | $215 → $155 | +13.19% | May 16, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $195 → $189 | Strong Buy | Maintains | $195 → $189 | +38.02% | May 7, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $219 | Strong Buy | Maintains | $219 | +59.92% | May 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $240 | Strong Buy | Reiterates | $240 | +75.26% | May 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $221 → $240 | Strong Buy | Maintains | $221 → $240 | +75.26% | Apr 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $221 → $240 | Strong Buy | Maintains | $221 → $240 | +75.26% | Apr 28, 2025 |
| Jefferies | Jefferies | Strong Buy Initiates $245 | Strong Buy | Initiates | $245 | +78.91% | Mar 5, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $221 | Strong Buy | Reiterates | $221 | +61.38% | Feb 28, 2025 |
| Citigroup | Citigroup | Hold Maintains $206 → $215 | Hold | Maintains | $206 → $215 | +57.00% | Feb 20, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $215 | Buy | Reiterates | $215 | +57.00% | Feb 20, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $212 → $218 | Strong Buy | Maintains | $212 → $218 | +59.19% | Feb 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $221 | Strong Buy | Reiterates | $221 | +61.38% | Feb 19, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $212 | Strong Buy | Maintains | $212 | +54.81% | Dec 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $221 | Strong Buy | Reiterates | $221 | +61.38% | Dec 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $221 | Strong Buy | Reiterates | $221 | +61.38% | Dec 13, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $212 | Strong Buy | Maintains | $212 | +54.81% | Dec 12, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.